SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

Lilly says Indy Religious Freedom law is discriminatory and may hamper cancer and AD drug development

Indiana’s new “religious freedom” law is discriminatory and will make it harder to attract the staff needed to develop drugs for cancer and Alzheimer's disease according to Eli Lilly.

RFPA Indianapolis protest - picture credit Justin Eagan

No more waiting for the Sun: FTC approves $4bn Ranbaxy acquisition

Sun Pharmaceutical Industries has completed its $4bn (€3.7bn) acquisition of Ranbaxy after receiving the thumbs up from the US Federal Trade Commission (FTC).

Aarti says US FDA has not detailed GMP problems that earned it an import ban

Aarti Drugs says the US FDA has not provided details of observations that earned its E-22 facility in Tarapur, India an import ban.

US FDA rejects Amgen bid to force biosims firms to share info before review

Biosimilar firms seeking US approval will not have to commit to share manufacturing data with reference drug firms before reviews, after the FDA rejected Amgen’s request for such a rule.

‘Game changer’: latest GDP rules spell full traceability for APIs

Makers and distributors of APIs (active pharmaceutical ingredients) will have to track their products throughout the supply chain and meet rules on cold chain transport and outsourcing under revised guidance from the European Commission.

Capsugel invests in vegetarian capsules citing demand for lower moisture content and API cross-linking risk

Capsugel will invest $25m (€22m) to expand production of vegetarian-friendly drug and food supplement capsules.

Spotlight

Distributing donated drugs a major challenge says UK neglected diseases group

Distributing donated drugs a major challenge says UK neglected diseases group

More drugs for tropical diseases have been donated since the London declaration of 2012, but getting them...

Novasep to make API for Celladon's heart attack gene therapy
update

Novasep joins Lonza as Mydicar API producer in deal with Celladon

Novasep and Lonza will both make the API for Celladon's heart attack therapy, Mydicar.

Lethal injection drug shortage brings return of firing squad in Utah

Lethal injection drug shortage brings return of firing squad in Utah

Utah will allow execution by firing squad as European pharmaceutical companies refuse to provide drugs for lethal...

Growing elderly population to drive drug excipients sector, study

Growth with aid of Grey: Elderly folks to drive excipients sector, study

Demand for pensioner friendly pills will be an important growth driver for the drug excipients sector according...

WHO calls for proactive strategies to combat falsified, substandard medicines

WHO calls for proactive strategies to combat falsified, substandard medicines

The WHO’s latest report on substandard/spurious/falsely-labelled/falsified/counterfeit (SSFFC) medical products has the organization divvying up certain responsibilities for...

US diabetics pay most for drugs, but world’s poorest bear the biggest economic burden

US diabetics pay most for drugs, but world’s poorest bear the biggest economic burden

Further evidence US diabetics pay more for drugs than sufferers in comparable countries has emerged this month...